As a research-driven company with more than 3500 employees worldwide, it continuously invests more than 11 % of its revenues in R&D. This is one of the highest rates in the industry. Boehringer Ingelheim Animal Health is driven by the wish to improve animal welfare as an integral part of a healthy future for mankind.
Numerous partnerships with academic institutions all around the world and Boehringer Ingelheim’s R&D in Human Pharmaceuticals provide a unique and effective scientific environment. International teams are working together in the worldwide network to bring innovative solutions to the marketplace for the benefit of our customers.